Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
277.00    -12.00 (-4.15%)
Bid:
275.00
Ask:
279.00
Spread: 4.00 (1.455%)
Market Cap: £248.99m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Pre-close Trading Statement

27 Mar 2009 07:07

RNS Number : 5916P
Norcros PLC
27 March 2009
 



Norcros plc

Pre-close Trading Update

Norcros, the home consumer products group, issues the following update for the year ending 31st March 2009 in advance of the preliminary results announcement.

 

We expect to report that Group revenues will be in the region of £152m (2008:£167.9m). Our UK operations have continued to trade resiliently given the market conditions and are expected to report trading profits of approximately £8.5m. Triton, our shower business, has performed particularly well. In South Africa, our operations have been impacted by further market softness, investment in new and existing stores, higher energy costs, exchange losses and by continued under-performance in our tile manufacturing business. We expect to report a trading loss in South Africa for the year of approximately £1.9m.

Overall, we expect to report Group trading profit in the region of £6.5m (2008:£16.0m). Profit before tax and exceptional items will be impacted by our equity share of the losses in our Greek associate business and a fair value adjustment in respect of interest rate swaps and is expected to be in the region of £3.0m (2008:£13.0m)We also expect to report exceptional charges of approximately £3.4m to reflect the cost reduction and restructuring programmes already announced and largely implemented throughout the Group, and approximately £4.0m reflecting an increase in the provision for onerous property leases, partly offset by an exceptional gain of £1.3m on the sale of the Group's investment in H&R Johnson (India) Ltd.

The closing net debt position is anticipated to be in the region of £48.0m (2008:£46.5m). We have agreed with our Banking Group an amendment and reset to our covenants for the 31st March 2009 test date and are engaged in discussions to agree an amendment and restatement of the terms of the £80m facility which is due to expire in July 2012. The Board is confident of concluding an agreement with the Banking Group ahead of our preliminary results announcement.

We have made good progress in our cost reduction programmes in all our businesses and expect to realise annualised savings in the region of approximately £4.0m. Our UK operations continue to more than hold their own in current markets and the issues in our South African operations are being decisively addressed following senior management changes and the closure of the inefficient wall tile facility. We remain confident that our shower, adhesive and tile brands are well positioned to take advantage of any market opportunities.

27 March 2009

ENQUIRES

Norcros plc

01625 549 010

Joe Matthews, Chief Executive

Nick Kelsall, Group Finance Director

Altium

0161 831 9133

Mike Fletcher/Paul Lines 

College Hill

020 7457 2020

Adam Aljewicz

Mark Garraway

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPUUAUWUPBUMM
Date   Source Headline
21st May 20267:00 amRNS-RInvestor Presentation Webinar on 18 June 2026
12th May 20267:00 amRNSStrategic update: South African operations
30th Apr 202611:42 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSYear-end Trading and Board update
2nd Apr 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSBlock Listing Six Monthly Return
3rd Mar 20269:29 amRNSDirectors Share Dealing - correction
3rd Mar 20267:00 amRNSDirectors Share Dealing
2nd Feb 20267:00 amRNSAppointment of Joint Corporate Broker
14th Jan 202612:12 pmRNSDirectors Share Dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
28th Nov 20254:03 pmRNSHolding(s) in Company
20th Nov 20256:22 pmRNSDirectors Share Dealing
20th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNS-RInvestor Presentation Webinar on 1 December 2025
21st Oct 20255:04 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSTrading update
13th Oct 20257:24 amRNSCompletion of Acquisition of Fibo Holding AS
30th Sep 202511:46 amRNSBlock Listing Six Monthly Return
23rd Jul 202512:03 pmRNSDirector Dealings - APSP and DBP Share Options
23rd Jul 202511:59 amRNSResults of AGM
23rd Jul 20257:11 amRNSAGM Trading Statement
21st Jul 20254:11 pmRNSDirector Dealings - DBP Share Option exercises
16th Jul 20255:01 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSAcquisition of Fibo Holding AS
23rd Jun 20257:00 amRNSJTSA Outcome of Strategic Review
20th Jun 20254:10 pmRNSAnnual Financial Report and Notice of 2025 AGM
12th Jun 20257:00 amRNSResults for the year ended 31 March 2025
3rd Jun 20257:00 amRNS-RInvestor Webinar
10th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
31st Mar 20257:00 amRNSBlock Listing 6 Monthly Return
31st Mar 20257:00 amRNSTotal Voting Rights
13th Mar 20257:00 amRNSPension Scheme Valuation Update
5th Feb 20253:45 pmRNSDirectors Share Dealing
31st Dec 20247:00 amRNSVoting Rights and Share Capital Update
10th Dec 202411:49 amRNSHolding(s) in Company
6th Dec 202411:52 amRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSTotal Voting Rights
21st Nov 20245:01 pmRNSHolding(s) in Company
21st Nov 202411:57 amRNSInterim Results - Replacement
21st Nov 20247:00 amRNSResults for the six months ended 30 September 2024
1st Nov 20247:00 amRNSTotal Voting Rights
10th Oct 20247:00 amRNSTrading update
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 202410:08 amRNSBlock listing Six Monthly Return
30th Aug 20247:00 amRNSTotal Voting Rights
24th Jul 20241:50 pmRNSResults of AGM
24th Jul 20241:24 pmRNSDirector Dealings - APSP Share Option Awards
24th Jul 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.